Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer. (Q38430341)
Jump to navigation
Jump to search
scientific article published on 14 May 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer. |
scientific article published on 14 May 2014 |
Statements
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer (English)
S L Geater
N Iannotti
S Thongprasert
A Spira
D Smith
L Reyderman
B Wang
P Gopalakrishna
F Garzon
L Xu
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference